Press Releases

WASHINGTON, Dec. 14 – Sen. Bernie Sanders (I-Vt.) Tuesday issued the following statement announcing his opposition to Dr. Robert Califf’s nomination to run the U.S. Food and Drug Administration (FDA): “At a time when the American people pay the highest prices in the world for prescription drugs and as drug companies continue to be the most powerful special interest in

Citing outrageous costs and safety concerns around Alzheimer’s drug, Sanders calls for Medicare to negotiate drug prices WASHINGTON, Dec. 3 – Sen. Bernie Sanders (I-Vt.) on Friday sent a letter to President Biden urging his administration to delay an increase in Medicare premiums coming in 2022 following the U.S. Food and Drug Administration’s (FDA) approval of the outrageously expensive Alzheimer’s

WASHINGTON, Dec. 3 – Sen. Bernie Sanders (I-Vt.) Friday announced the largest ever investment of federal funds, both in Vermont and across the country, to bolster health care workforces in rural and underserved communities through loan repayments and scholarship programs. The historic $1.5 billion – made possible largely by the $1 billion in supplemental funding authorized through the American Rescue

WASHINGTON, Nov. 30 – Sen. Bernie Sanders (I-Vt.) Tuesday issued the following statement amid developing reports of the new Omicron coronavirus variant and the recent move by the World Trade Organization to postpone a major Ministerial Conference in Geneva: “Nearly a year since vaccinations began to roll out here in the U.S. and while too many of our neighbors around

WASHINGTON, Nov. 23 – Sen. Bernie Sanders (I-Vt.), along with Sens. Tammy Baldwin (D-Wisc.), Sherrod Brown (D-Ohio), and Elizabeth Warren (D-Mass.), Tuesday sent a letter to the Biden Administration pushing for a waiver of international intellectual property (IP) rules at the World Trade Organization (WTO) to boost production of COVID-19 vaccines for the developing world. This comes as the WTO Ministerial